Loading...
EMA Reviews And Rare Disease Trends Will Open Global Markets
AnalystConsensusTarget's Fair Value
US$14.00
86.7% undervalued intrinsic discount04 Sep
US$1.86
1Y
70.6%7D
-21.2%1Y
70.6%7D
-21.2%You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.